Search

Search Constraints

You searched for: Author/Creator Sandmann, Thomas

Search Results

1. Fibrillar Aβ causes profound microglial metabolic perturbations in a novel APP knock‐in mouse model. (1st February 2022)

2. Fibrillar Aβ causes profound microglial metabolic perturbations in a novel APP knock‐in mouse model. (December 2021)

3. Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study. Issue 4 (21st March 2019)

4. Radiologic progression of glioblastoma under therapy—an exploratory analysis of AVAglio. Issue 4 (1st September 2017)